ExLibris header image
SFX Logo
Title: Cancer. A bull's eye for targeted lung cancer therapy
Source:

Science [0036-8075] Minna, J D yr:2004


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Baselga, J. "Targeting Tyrosine Kinases in Cancer: The Second Wave." Science 312.5777 (2006): 1175-1178. Link to SFX for this item
2. Engelman, Jeffrey A. "Targeting PI3K signalling in cancer: Opportunities, challenges and limitations." Nature Reviews. Cancer 9.8 (2009): 550-562. Link to Full Text for this item Link to SFX for this item
3. Karnoub, AE E. "Ras oncogenes: split personalities." Nature reviews. Molecular cell biology 9.7 (2008): 517-531. Link to Full Text for this item Link to SFX for this item
4. Reynolds, A B. "SRChing for the substrates of Src." Oncogene 33.37 (2014): 4537-4547. Link to Full Text for this item Link to SFX for this item
5. Der, P. J. "Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer." Oncogene 26.22 (2007): 3291-3310. Link to Full Text for this item Link to SFX for this item
6. Vogt, Peter K K. "Cancer-specific mutations in phosphatidylinositol 3-kinase." Trends in biochemical sciences 32.7 (2007): 342-349. Link to SFX for this item
7. Pagliarini, R. "Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure." EMBO reports 16.3 (2015): 280-296. Link to Full Text for this item Link to SFX for this item
8. Cheng, H. "Targeting the phosphoinositide 3-kinase pathway in cancer." Nature Reviews. Drug Discovery 8.8 (2009): 627-44. Link to Full Text for this item Link to SFX for this item
9. Hennessy, Bryan T T. "Exploiting the PI3K/AKT pathway for cancer drug discovery." Nature reviews. Drug discovery 4.12: 988-1004. Link to SFX for this item
10. Bollag, G. "Hyperactive Ras in developmental disorders and cancer." Nature reviews. Cancer 7.4 (2007): 295-308. Link to Full Text for this item Link to SFX for this item
11. Malumbres, M. "Cell cycle, CDKs and cancer: a changing paradigm." Nature reviews. Cancer 9.3 (2009): 153-66. Link to Full Text for this item Link to SFX for this item
12. Kolch, W. "MAP kinase signalling pathways in cancer." Oncogene 26.22 (2007): 3279-90. Link to Full Text for this item Link to SFX for this item
13. Lewin, B. "Oncogenic conversion by regulatory changes in transcription factors." Cell 64.2 (1991): 303-312. Link to Full Text for this item Link to SFX for this item
14. Weir, Marion E. "Novel autophosphorylation sites of Src family kinases regulate kinase activity and SH2 domain-binding capacity." FEBS letters 590.8 (2016): 1042-1052. Link to Full Text for this item Link to SFX for this item
15. Hebert Chatelain, E. "Src kinases are important regulators of mitochondrial functions." International journal of biochemistry & cell biology 45.1 (2012): 90-98. Link to SFX for this item
16. Bishop, J M M. "Molecular themes in oncogenesis." Cell 64.2 (1990): 235-48. Link to Full Text for this item Link to SFX for this item
17. Raman, M. "Differential regulation and properties of MAPKs." Oncogene 26.22 (2007): 3100-3112. Link to Full Text for this item Link to SFX for this item
18. Zimmermann, S. "Phosphorylation and regulation of Raf by Akt (protein kinase B)." Science 286.5445 (1999): 1741-4. Link to SFX for this item
19. Odorizzi, G. "Phosphoinositide signaling and the regulation of membrane trafficking in yeast." Trends in biochemical sciences 25.5 (2000): 229-235. Link to Full Text for this item Link to SFX for this item
20. Vanhaesebroeck, B. "New responsibilities for the PI3K regulatory subunit p85 alpha." Science's STKE 2001.65 (2000). Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced